BioCentury
ARTICLE | Company News

Oncor deal

October 3, 1994 7:00 AM UTC

The genetic testing company acquired Appligene S.A., a French developer of molecular genetic products, for $2.2 million in cash, notes with an aggregate principal amount of $4.3 million and 636,000 sh...